At a glance
ClinicalIndex Comparison RecordN/ACompleted· 183 enrolled
Drug / intervention
Multiple-Segment spectacle lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Clinical Trial of Myopia Control in Schoolchildren Using the Multi-segment (MS) Lens
In Brief
A clinical study evaluating Multiple-Segment spectacle lens for Myopia. Completed, enrolled 183 participants across 2 sites in 2 countries.
Detailed Summary
The purpose of this study is to determine if the Multiple-Segment (MS) spectacle lens can slow myopia progression in Hong Kong schoolchildren. MS lens is also called Defocus Incorporated Multiple Segments (DIMS) spectacle lens
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesChina, Hong Kong
CollaboratorsHoya Vision Care
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartAug 2014
Primary CompletionJul 2017
TodayJul 2026
First PostedAug 1, 2014
Enrollment StartAug 1, 2014
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.9 years ago
Interventions
Multiple-Segment spectacle lensdevice
A multifocal spectacle lens that corrects distance refraction and provides myopic defocus images simultaneously. The myopic defocus aims at slowing down myopia progression.